Amendment 6
ANNEX
Annex I, point [XX]a (new) (Directive 76/769/EEC)
[XX]a. diphenylether, octabromo derivativeC
12H2Br 8O
1. May not be placed on the market or used as a substance
or as a constituent of preparations in concentrations higher
than 0,1 % by mass.
2. Articles may not be placed on the market if they, or
flameretarded parts thereof, contain this substance in concen-
trations higher than 0,1 % by mass.
Amendment 16
ANNEX
Annex I, point [XX]b (new) (Directive 76/769/EEC)
[XX]b. diphenylether, decabromo derivativeC
12H2Br10O
1. May not be placed on the market or used as a substance
or as a constituent of preparations in concentrations higherthan 0,1 % by mass.
2. Articles may not be placed on the market if they, or
flameretarded parts thereof, contain this substance in concen-trations higher than 0,1 % by mass.
3. These provisions shall apply at the latest from 1 January
2006 onwards, unless the risk assessment according to Regu-lation (EEC) 793/93 concludes that decaBDE gives no causefor concern.
European Parliament legislative resolution on the proposal for a European Parliament and Councildirective amending for the 24th time Council Directive 76/769/EEC relating to restrictions on themarketing and use of certain dangerous substances and preparations (pentabromodiphenyl ether)
(COM(2001) 12  C5-0018/2001  2001/0018(COD))
(Codecision procedure: first reading)
The European Parliament,
 having regard to the Commission proposal to the European Parliament and the Council
(COM(2001) 12) (
1),
 having regard to Article 251(2) and Article 95 of the EC Treaty, pursuant to which the Commission
submitted the proposal to Parliament (C5-0018/2001),
 having regard to Rule 67 of its Rules of Procedure, having regard to the report of the Committee on the Environment, Public Health and Consumer Policy
(A5-0271/2001),
(1) OJ C 154 E, 29.5.2001, p. 112.C 72 E/288 EN 21.3.2002 Official Journal of the European Communities
Thursday 6 September 2001
TEXT PROPOSED
BY THE COMMISSIONAMENDMENTS
BY PARLIAMENT
1. Approves the Commission proposal as amended;
2. Asks to be consulted again should the Commission intend to amend the proposal substantially or
replace it with another text;
3. Instructs its President to forward its position to the Council and Commission.
3. Quality and safety standards for human blood and blood components ***I
A5-0272/2001
Proposal for a European Parliament and Council directive setting standards of quality and safety
for the collection, testing, processing, storage, and distribution of human blood and blood com-ponents and amending Council Directive 89/381/EEC (COM(2000) 816  C5-0034/2001  2000/
0323(COD))
The proposal was amended as follows:
TEXT PROPOSED
BY THE COMMISSION (1)AMENDMENTS
BY PARLIAMENT
Amendment 1
RECITAL 1A (new)
(1a) Article 3(2) of the European Union Charter on Funda-
mental Rights prohibits making the human body and itsparts a source of financial gain. This also applies to humanblood, regardless of its state (liquid, solid, frozen, freeze-driedetc.). Blood is not a commodity but a gift from one humanbeing to another given without regard to the recipients race,religion, nationality, and so forth. A higher degree of safetywill increase confidence in the blood supply system which willinter alia increase donors readiness to donate blood. Largenumbers of donors are essential for the critical selection ofsuitable donors, and for the level of self-sufficiency. The
shortage of blood donated unpaid is the greatest threat to
the safety of Community blood supplies. A directive seekingto achieve a high degree of security for Community bloodsupplies should therefore include measures to recruit andretain suitable donors, and schemes to reduce dependency onblood imported from non-Community countries. If donors areto be unpaid, the blood supply system must also be non-com-mercial. The processing of blood at all stages is a service car-ried out for the Member States health services for the benefitof patients.
Amendment 2
RECITAL 2
(2) The availability of blood and blood components used for
therapeutic purposes is dependent on Community citizens whoare prepared to donate; in order to safeguard public health and(2) The availability of blood and blood components used for
therapeutic purposes is dependent on Community citizens whoare prepared to donate. In order to safeguard public health and21.3.2002 EN C 72 E/289 Official Journal of the European Communities
Thursday 6 September 2001
(1) OJ C 154 E, 29.5.2001, p. 141.